Ticker: XBI CUSIP: 78464A870 Class: S&P BIOTECH
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 83,176 | $10,142 | — | — |
| Q3 2025 | 83,176 | $8,334 | — | — |
| Q2 2025 | 138,297 | $11,469 | — | — |
| Q1 2025 | 83,176 | $6,746 | — | — |
| Q4 2024 | 83,176 | $7,491 | — | — |
| Q3 2024 | 98,292 | $9,711 | — | — |
| Q2 2024 | 83,176 | $7,711 | — | — |
| Q1 2024 | 4,305 | $409 | — | — |
| Q3 2023 | 83,176 | $6,074 | — | — |
| Q2 2023 | 83,176 | $6,920 | — | — |
| Q1 2023 | 83,176 | $6,339 | — | — |
| Q4 2022 | 83,176 | $6,904 | — | — |
| Q3 2022 | 98,176 | $7,787 | — | — |
| Q2 2022 | 98,176 | $7,292 | — | — |
| Q1 2022 | 39,791 | $3,576 | — | — |
| Q4 2021 | 19,271 | $2,158 | — | — |
| Q3 2021 | 13,801 | $1,735 | — | — |
| Q1 2021 | 25,000 | $3,391 | — | — |
| Q4 2013 | 33,794 | $4,400 | — | — |
| Q3 2013 | 5,155 | $666 | — | — |
| Q2 2013 | 25,420 | $2,650 | — | — |